Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 5/20 | 0.53 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 7/20 | 0.42 |
| ▸ | GALR3 | O60755 | 1/20 | 0.41 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.41 |
| ▸ | UMPS | P11172 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiazofurin SCHEMBL4453888 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL13109276 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL2883657 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL23264566 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL2883659 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL23848843 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL7169632 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL4287 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| Tiazofurin SCHEMBL1651851 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| SCHEMBL12901995 | 0.87 | PYGL (0.52) | PYGLSLC5A2GALR3NR2F2UMPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4451648-A | VIRICIDE BY MULTI-STEP PROCESS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-05-29 | — | — | US | claimed |
| EP-0072977-A1 | Process for the production of 2-beta-D-ribofuranosylthiazole-4-carboxamide | Starks Associates, Incorporated (US) | 1983-03-02 | — | — | EP | claimed |
| EP-1000075-A4 | METHOD OF PRODUCING TIAZOFURIN AND OTHER C-NUCLEOSIDES | ICN PHARMACEUTICALS (US) | 2001-09-05 | — | — | EP | disclosed |
| EP-1000075-A1 | METHOD OF PRODUCING TIAZOFURIN AND OTHER C-NUCLEOSIDES | ICN Pharmaceuticals, Inc. (US) | 2000-05-17 | — | — | EP | disclosed |
| US-5907036-A | Procedures for obtaining ribo-C-nucleosides | ICN PHARMACEUTICALS, INC. (US) | 1999-05-25 | — | — | US | disclosed |
| WO-1999000399-A1 | METHOD OF PRODUCING TIAZOFURIN AND OTHER C-NUCLEOSIDES | ICN PHARMACEUTICALS, INC. (US) | 1999-01-07 | — | — | WO | disclosed |
| EP-0804447-A1 | PROCEDURES FOR OBTAINING RIBO-C-NUCLEOSIDES | ICN Pharmaceuticals, Inc. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996026212-A1 | PROCEDURES FOR OBTAINING RIBO-C-NUCLEOSIDES | ICN PHARMACEUTICALS, INC. (US) | 1996-08-29 | — | — | WO | disclosed |
| US-4451648-A | VIRICIDE BY MULTI-STEP PROCESS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-05-29 | — | — | US | disclosed |
| EP-0072977-A1 | Process for the production of 2-beta-D-ribofuranosylthiazole-4-carboxamide | Starks Associates, Incorporated (US) | 1983-03-02 | — | — | EP | disclosed |
| EP-0072977-A1 | Process for the production of 2-beta-D-ribofuranosylthiazole-4-carboxamide | Starks Associates, Incorporated (US) | 1983-03-02 | — | — | EP | disclosed |